Mario Negri Institute For Pharmacological Research
Clinical trials sponsored by Mario Negri Institute For Pharmacological Research, explained in plain language.
-
New combo therapy shows promise for rare liposarcoma
Disease control CompletedThis study tested whether adding pioglitazone (a diabetes drug) to trabectedin (a chemotherapy) can help shrink or control liposarcoma, a rare cancer of fat tissue. It included 10 adults whose cancer had stopped growing but not shrunk after at least 4 cycles of trabectedin alone.…
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated May 26, 2026 03:29 UTC
-
School and family programs aim to stop childhood obesity before it starts
Prevention CompletedThis completed study tested whether programs involving schools and families could help prevent childhood obesity. Researchers worked with 226 children aged 6-11 to promote healthy eating and active lifestyles. The goal was to see if these combined efforts could reduce the risk of…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Prevention
Last updated May 19, 2026 12:00 UTC
-
Bergamo gene discovery may explain kidney disease patterns
Knowledge-focused CompletedThis study looked at 10 people with a kidney disease called ADPKD to see if a specific gene change (a deletion in the PKD2 gene) is common in families from the Bergamo area. Researchers interviewed participants about their health and family history to understand how this gene cha…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated May 26, 2026 03:30 UTC
-
Scientists probe immune cells to unlock kidney disease treatment secrets
Knowledge-focused CompletedThis study looked at blood samples from 48 people with membranous nephropathy, a kidney disease, to see how treatments that deplete B-cells affect specific immune cells linked to the disease. Researchers measured levels of PLA2R-specific B-cells before and after therapy to unders…
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC